Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URANUS feasibility trial in upper tract urothelial carcinoma
NL-OMON48801Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in upper tract urothelial carcinoma (UTUC), sponsored by Leiden University Medical Center. Started May 2018; status: recruiting.
02
Drugs
cisplatin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NL-OMON48801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48801.